C. Zuccato

Simvastatin and the Rho‐kinase inhibitor Y‐27632 prevent myofibroblast transformation in Peyronie's disease‐derived fibroblasts via inhibition of YAP/TAZ nuclear translocation

M. Albersen, D. de Ridder, U. Milenkovic, 2019, BJU international.